頁籤選單縮合
題 名 | 培力藥品公司--尋找新機會的歷程=Pei Li Pharmaceutical Corporation: A Process of Searching for New Opportunity |
---|---|
作 者 | 鄭祥麟; 李雨師; 邱世寬; | 書刊名 | 產業與管理論壇 |
卷 期 | 16:1 2014.03[民103.03] |
頁 次 | 頁70+72-80 |
分類號 | 418.61 |
關鍵詞 | 中小型國產藥廠; 製藥產業; 營運模式; Small- to medium-scale domestic pharmaceutical company; Pharmaceutical industry; Operating model; |
語 文 | 中文(Chinese) |
中文摘要 | 培力藥品公司是一家專注於健保給付處方藥(學名藥)市場的中小型國產藥廠,面對健保制度主導製藥產業、國際藥廠以雄厚的資金與優異的研發能力進攻台灣市場、目標市場面臨大量國產藥廠低價掠奪,培力藥品公司如何在產業高度競爭下,持續成長並選擇適合的營運模式,此課題正考驗著公司領導者郭榮昌董事長的經營智慧。 |
英文摘要 | Pei Li Pharm is a small- to medium-scale domestic pharmaceutical company focused on the research and production of prescription drugs (generic drugs) covered by the National Health Insurance (NHI) scheme. Because of the NHI’s dominance of the pharmaceutical industry, international pharmaceutical companies enter the Taiwan market with significant capital and outstanding research and development abilities. By contrast, domestic pharmaceutical companies adopt a low-price policy to retain their market share. In this highly competitive industry, the continued growth of Pei Li Pharm, and adoption of an appropriate operating model, is dependent on the chairman’s (Rong-Chang Guo) business intelligence. |
本系統中英文摘要資訊取自各篇刊載內容。